ANDA 202301, held by Micro Labs Ltd. Efavirenz.
As of Nov 16, 2026, ANDA 202301 (Efavirenz), held by Micro Labs Ltd, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 20, 2012 | Original application | Tentative approval |
| Product | Active ingredient | Marketing |
|---|---|---|
| Efavirenz600MG ยท tablet; oral | Efavirenz | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters